# Perioperative Chemoradiotherapy for Potentially Resectable Gastric Cancer

> **NCT00420394** · PHASE2 · UNKNOWN · sponsor: **Soroka University Medical Center** · enrollment: 30 (estimated)

## Conditions studied

- Stomach Neoplasms

## Interventions

- **PROCEDURE:** Chemotherapy
- **PROCEDURE:** surgery
- **PROCEDURE:** radiotherapy

## Key facts

- **NCT ID:** NCT00420394
- **Lead sponsor:** Soroka University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2007-04
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2007-06-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00420394

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00420394, "Perioperative Chemoradiotherapy for Potentially Resectable Gastric Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00420394. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
